Log-in / Create Account  
 
DIA 2013 49th Annual Meeting
Click here to go to the previous page
Approaches to Quality Risk Management: Understanding What Matters
Track : Track 02: Project/Portfolio Management and Strategic Planning
Program Code: 244
Date: Tuesday, June 25, 2013
Time: 1:45 PM to 3:15 PM  EST
Location: 253A
CHAIR :
 Martin Landray, PhD,FRCP (SCHSUP), Reader in Epidemiology, Clinical Trial Service Unit, University of Oxford, United Kingdom
SPEAKER (S):
 Martin Landray, PhD,FRCP (SCHSUP), Reader in Epidemiology, Clinical Trial Service Unit, University of Oxford, United Kingdom
Behm C. Mark, Senior Director, Compliance Advice and Assurance, AstraZeneca LP, United States
 Ann Meeker-O'Connell, MS (SPKAGY), Senior Director, QA Clinical Strategy Team Lead, Janssen Pharmaceutica Inc., United States
Description
This forum will review the Clinical Trials Transformation Initiative's (CTTI) potential methods to apply principles of Quality by Design and quality risk management to the scientific and operational design of clinical trials.

Session Recording
(Code: 244)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON3 Comp Access: Tuesday Online Access Package - June 25, 2013
Handout Online
(Code: 244)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON3 Comp Access: Tuesday Online Access Package - June 25, 2013
Approaches to Quality Risk Management: Understanding What Matters